Announcements Trials
Browse Landscape

Phase

Phase 1/2 1Phase 1 1

Status

Unknown 1Completed 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

CNS 2Sarcoma 1

Conditions

Leukemia 22Leukemia, Promyelocytic, Acute 21Leukemia, Myeloid, Acute 13Multiple Myeloma 11Myelodysplastic Syndromes 9Leukemia, Myelomonocytic, Chronic 8Neoplasms, Plasma Cell 7Precursor Cell Lymphoblastic Leukemia-Lymphoma 5Leukemia, Monocytic, Acute 5Anemia, Refractory, with Excess of Blasts 5Neoplasms 4Lymphoma 4Leukemia, Myelomonocytic, Acute 4Leukemia, Myelogenous, Chronic, BCR-ABL Positive 4Leukemia, Megakaryoblastic, Acute 4Leukemia, Lymphocytic, Chronic, B-Cell 4Leukemia, Erythroblastic, Acute 4Central Nervous System Neoplasms 4Blast Crisis 4Recurrence 3Neuroblastoma 3Neoplasm Metastasis 3Myeloproliferative Disorders 3Myelodysplastic-Myeloproliferative Diseases 3Lymphoma, Non-Hodgkin 3Lymphoma, Mantle-Cell 3Lymphoma, Large-Cell, Immunoblastic 3Lymphoma, Large B-Cell, Diffuse 3Lymphoma, Follicular 3Leukemia, Myeloid, Chronic-Phase 3

Interventions

Radiosurgery 114Temozolomide 104Bevacizumab 71Radiotherapy 67Magnetic Resonance Spectroscopy 67Carboplatin 29pembrolizumab 28Irinotecan 26Surgical Procedures, Operative 25Radiation 23Nivolumab 23Etoposide 22Magnetic Resonance Imaging 21Ipilimumab 21Erlotinib Hydrochloride 21Cyclophosphamide 21Surveys and Questionnaires 19Aminolevulinic Acid 18Specimen Handling 16Pemetrexed 16Mental Status and Dementia Tests 16Cisplatin 16Carmustine 15Topotecan 14Trastuzumab 13Saline Solution 12Neuropsychological Tests 12Gefitinib 11Filgrastim 11Drug Therapy 11

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
OTHER × Brain Neoplasms × Arsenic Trioxide × Clear all
NCT00275067 2020-02-25

Arsenic Trioxide, Temozolomide, and Radiation Therapy in Treating Patients With Malignant Glioma That Has Been Removed By Surgery

Northwestern University

Phase 1/2 Unknown
50 enrolled
CNSSarcoma

Astrocytoma, Brain Neoplasms, Glioblastoma, Glioma, Oligodendroglioma, Central Nervous System Neoplasms, Gliosarcoma

NCT00185861 2009-04-09

Phase I Trial of Arsenic Trioxide and Stereotactic Radiotherapy for Recurrent Malignant Glioma

Stanford University

Phase 1 Completed
12 enrolled
CNS

Brain Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡